Orthopedia - KIDS STOCK NEWS

OrthoPediatrics Corp. (Nasdaq: KIDS) announced preliminary unaudited net revenue for Q4 2022 at $31.0 million, a 25% increase from $24.8 million in Q4 2021. Full year 2022 net revenue is projected at $122.3 million, up 25% from $98.0 million in 2021. Domestic revenue grew 19% and international revenue increased by 47%. For 2023, the company forecasts net revenue between $146.0 million and $149.0 million, reflecting a growth of 20% to 22%. The report highlighted challenges due to surgery schedule disruptions in children's hospitals due to viral infections but emphasized a strong strategic position.

OrthoPediatrics Corp. (Nasdaq: KIDS) has launched a direct sales organization in Germany, commencing operations on January 1, 2023. This marks its first direct international presence, reflecting a commitment to enhance pediatric orthopedics globally. The new entity, OrthoPediatrics GmbH, aims to better address the unique needs of the German pediatric community, one of Europe’s largest orthopedic markets. The company will continue partnerships with local organizations to support pediatric orthopedic education. OrthoPediatrics offers a comprehensive range of products targeting trauma, deformity correction, and spinal issues.

OrthoPediatrics Corp. (Nasdaq: KIDS) announced its participation as a Double Diamond sponsor at the upcoming IPOS event, taking place from December 6-10, 2022, in Orlando, Florida. This event will feature over 500 pediatric orthopedic surgeons and aims to foster education and networking opportunities. CEO David Bailey expressed excitement about collaborating with surgeon customers to enhance pediatric orthopedic care. Notable events include a pre-course on surgical errors and various spotlight sessions covering pediatric orthopedic techniques.

OrthoPediatrics Corp. (Nasdaq: KIDS) has announced that CEO Dave Bailey and COO/CFO Fred Hite will participate in fireside chats at two upcoming investor conferences. The first event is the Stifel 2022 Healthcare Conference on November 16, 2022, at 9:45 am ET, followed by the Piper 34th Annual Healthcare Conference on November 30, 2022, at 2:30 pm ET. Audio webcasts of these discussions will be available on the company's investor relations website, with replays accessible for 90 days post-event.

OrthoPediatrics focuses exclusively on pediatric orthopedics, offering 46 surgical systems worldwide.

OrthoPediatrics Corp. (KIDS) reported a 39% revenue increase for Q3 2022, reaching $35.0 million, driven by growth in Trauma & Deformity and Scoliosis segments.

Net income soared to $18.5 million, compared to a loss of $2.2 million a year prior. Despite external challenges, including RSV infections affecting case volumes, the company remains optimistic about sustainable growth.

Full-year revenue is projected at $124 million to $125 million, revised from an earlier estimate of $127 million to $130 million.

OrthoPediatrics Corp. (Nasdaq: KIDS) appointed Jimmy D. McDonald to its board of directors, effective October 18, 2022. McDonald, currently the Chief Supply Chain Officer at TE Connectivity, brings extensive experience in procurement and logistics, overseeing a $7.2 billion annual supplier spend. His appointment is expected to enhance OrthoPediatrics' operations, given his background in managing complex supply chains. McDonald expressed his commitment to improving children's lives through orthopedic solutions, aligning with OrthoPediatrics' mission.

OrthoPediatrics Corp. (NASDAQ: KIDS) will release its third quarter 2022 financial results on October 31, 2022, after the market closes. A conference call is scheduled for November 1, 2022, at 8:00 a.m. ET to discuss these results. The company, founded in 2006, focuses on pediatric orthopedics, offering 39 surgical systems across various categories, including trauma, scoliosis, and sports medicine. OrthoPediatrics operates in the U.S. and 70 international markets, aiming to improve pediatric orthopedic care.

OrthoPediatrics Corp. (Nasdaq: KIDS) announced it will present at the Inaugural Gilmartin Group Emerging Growth Company Showcase on August 31, 2022, at 2:00 PM ET. The company specializes in pediatric orthopedics, offering 39 surgical systems across trauma, deformity, scoliosis, and sports medicine categories. Interested parties can access the live webcast and archived presentation via the OrthoPediatrics website. Founded in 2006, the company is dedicated to improving the lives of children with orthopedic conditions, and distributes its products in the USA and 70 other countries.

OrthoPediatrics Corp. (Nasdaq: KIDS) has successfully closed its public offering of 1,091,250 shares at $55.00 each and pre-funded warrants for 1,525,000 shares at $54.99975. This transaction generated gross proceeds of approximately $144 million. The largest investor, Squadron Capital LLC, purchased the pre-funded warrants, which must be exercised upon meeting specific conditions. The net proceeds will support investments in equipment, R&D, debt repayment, and marketing efforts.